These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1154316)

  • 1. Post-transfusion hepatits following the use of prothrombin complex concentrates.
    Roberts HR; Blatt PM
    Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic evidence of hepatitis B virus infection in patients with hemophilia B. a multicenter study.
    Hoofnagle JH; Aronnon D; Roberts H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):606-9. PubMed ID: 1154315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor IX concentrates .
    Ménaché D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):600-5. PubMed ID: 1154314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary report and recommendations of the task force members and consultants.
    Ménachd ; Roberts HR
    Thromb Diath Haemorrh; 1975 Jun; 33(3):645-7. PubMed ID: 1154320
    [No Abstract]   [Full Text] [Related]  

  • 6. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 7. Technical aspects and results of the determination of hepatitis associated antigen (HAA) and antibody.
    Brummelhuis HG
    Vox Sang; 1970; 19(3):228-33. PubMed ID: 4993776
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Clinical use of prothrombin complex and risk of hepatitis.
    Kaeser A
    Thromb Diath Haemorrh; 1975 Dec; 34(3):877-8. PubMed ID: 1209555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis following blood transfusions].
    Busch H; Roos D; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201
    [No Abstract]   [Full Text] [Related]  

  • 10. Prothrombin complex concentrates for clinical use.
    Chandra S; Brummelhuis HG
    Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

  • 12. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
    Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
    [No Abstract]   [Full Text] [Related]  

  • 13. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
    Mosley JW
    Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australia antigen and post-transfusion hepatitis.
    Taylor DG
    J Tenn Med Assoc; 1973 Apr; 66(4):351-2. PubMed ID: 4696863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does a "hepatitis C" besides hepatitis B play an important part in blood transfusion disorders?].
    Frösner G
    Internist (Berl); 1976 May; 17(5):256-7. PubMed ID: 58848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Remarks on the problem of Australia antigen as an etiologic factor in the outbreak of viral hepatitis].
    Drews J; Sachs V; Waldvogel B
    Dtsch Med Wochenschr; 1971 Nov; 96(48):1893-4. PubMed ID: 5119935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Australia antigen and transfusion hepatitis. A prospective study on the frequency and prevention of transfusion hepatitis].
    Berthold H; Kleine N; Müller G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):230-4. PubMed ID: 4145571
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of Australia-antibody in blood donors. Study of liver histology in donors and post-transfusion hepatitis in recipients.
    Reinicke V; Poulsen H; Banke O; Dybkjaer E
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):753-6. PubMed ID: 4205739
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transmission of hepatitis C by factor concentrates].
    Aguilar C; Lucía JF
    Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
    [No Abstract]   [Full Text] [Related]  

  • 20. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
    Heimburger N; Karges HE; Weidmann E
    Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.